Abstract
Background
Hand osteoarthritis (HOA) is one of the most common causes of pain and functional disability in western countries and there is still no definitive cure. Low-dose radiation therapy (LDRT) has anti-inflammatory properties that have shown to be effective in the symptomatic relief of various degenerative musculoskeletal disorders. We designed a clinical protocol using LDRT for symptomatic HOA and present results and tolerance in the first 100 patients included.
Materials and methods
Between April 2015 and March 2021, 100 patients with a median age of 60 were treated. Fifty-seven patients suffering from proximal/distal interphalangeal joint pain, 40 patients with thumb arthritis, 2 patients with radiocarpal joint affection and 1 patient with metacarpophalangeal joint pain were enrolled. LDRT comprised of 6 fractions of 0.5–1 Gy on every other day up to a total dose of 3–6 Gy. Clinical response was evaluated according to the visual analog scale (VAS) for pain level and the von Pannewitz score (VPS) for joint functionality. Any patients not achieving subjective adequate pain relief after 8 weeks of treatment were offered a second identical LDRT course.
Results
With a median follow-up of 10.5 months (range 7.55–12.45), 94% reported an improvement in the pain, with a significant reduction in the VAS level after 3, 6 and 12 months (p < 0.001). Sixty-three patients needed a second course of treatment at a median time interval of 12 weeks (range 9–14). The mean VAS score before treatment was 8 (range 3–10). After treatment, it was 5 (range 1–10). After 3, 6 and 12 months, the mean VAS scores were 4 (range 0–9), 3 (range 0–9) and 3.5 (range 0–9), respectively. Seventy patients reported functionality improvements after LDRT according to the von Pannewitz score. No acute or late complications were observed.
Conclusion
LDRT appears to be safe and useful for HOA and is associated with good rates of pain relief and functionality improvements. However, further studies are necessary to confirm these promising results.
Similar content being viewed by others
Data availability
All data will be available at a reasonable request.
References
European League Against Rheumatism (EULAR) Position Paper Horizon 2020. Framework Program EULAR’s position and recommendations, November 2011 https://www.eular.org/myUploadData/files/EU_Horizon_2020_EULAR_position_paper.pdf
van der Pas S, Castell MV, Cooper C, Denkinger M, Dennison EM, Edwards MH, et al. European project on osteoarthritis: design of a six-cohort study on the personal and societal burden of osteoarthritis in an older European population. BMC Musculoskelet Disordord. 2013;14:138. https://doi.org/10.1186/1471-2474-14-138.
Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, labor productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford). 2014;53(5):937–47. https://doi.org/10.1093/rheumatology/ket463 (Epub 2014 Jan 30).
Vina ER, Kwoh CK. Osteoarthritis epidemiology: literature update. Curr Opin Rheumatol. 2018;30(2):160–7. https://doi.org/10.1097/BOR.0000000000000479.PMID:29227353.
Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis—an untreatable disease? Nat Rev Drug Discov. 2005;4(4):331–44 (Review. Erratum in: Nat Rev Drug Discov. 2005 Jul;4(7):543).
Kloppenburg M, Kwok WY. Osteoarthritis of the hand: a heterogeneous disorder. Nat Rev Rheumatol. 2011;8(1):22–31. https://doi.org/10.1038/nrrheum.2011.170.
Hermann W, Lambova S, Muller-Ladner U. Current treatment options for osteoarthritis. CurrRheumatol Rev. 2018;14(2):108–16. https://doi.org/10.2174/1573397113666170829155149.
Arenas M, Sabater S, Hernández V, Rovirosa A, Lara PC, Biete A, Panés J. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 2012;188(11):975–81. https://doi.org/10.1007/s00066-012-0170-8.
Rödel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007;83(6):357–66. https://doi.org/10.1080/09553000701317358.
Seegenschmiedt MH, Micke O, Muecke R, German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD). Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol. 2015;88(1051):20150080. https://doi.org/10.1259/bjr.20150080.
Micke O, Seegenschmiedt MH, Adamietz IA, Kundt G, Fakhrian K, Schaefer U, Muecke R, German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD). Low-dose radiation therapy for benign painful skeletal disorders: the typical treatment for the elderly patient? Int J Radiat Oncol Biol Phys. 2017;98(4):958–63. https://doi.org/10.1016/j.ijrobp.2016.12.012.
Juniku N, Micke O, Seegenschmiedt MH, Muecke R. Radiotherapy for painful benign skeletal disorders: results of a retrospective clinical quality assessment. Strahlenther Onkol. 2019;195(12):1068–73. https://doi.org/10.1007/s00066-019-01514-w.
Von Pannewitz G. Roentgen therapy for deforming arthritis. In: Holfelder H, Holthausen H, Juengling O, Martius H, Schinz HR, editors. Ergebnisse der medizinischen Strahlenforschung. Leipzig: Thieme; 1933. pp. 61–126.
Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf
Rödel F, Frey B, Manda K, et al. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose X-irradiation. Front Oncol. 2012;2:120. https://doi.org/10.3389/fonc.2012.00120 (Published 2012 Sep 25).
Lödermann B, Wunderlich R, Frey S, Schorn C, Stangl S, Rödel F, Keilholz L, Fietkau R, Gaipl US, Frey B. Low dose ionising radiation leads to a NF-κB dependent decreased secretion of active IL-1β by activated macrophages with a discontinuous dose-dependency. Int J Radiat Biol. 2012;88(10):727–34. https://doi.org/10.3109/09553002.2012.689464.
Park SH, Lee JE. Radiotherapy, a new treatment option for non-malignant disorders: radiobiological mechanisms, clinical applications, and radiation risk. J Rheum Dis. 2017;24(2):74–84.
Jansen JT, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM. Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol. 2005;76(3):270–7. https://doi.org/10.1016/j.radonc.2005.06.034.
Trott KR, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol. 2006;182(8):431–6. https://doi.org/10.1007/s00066-006-1542-8.
Mazonakis M, Damilakis J. Cancer risk after radiotherapy for benign diseases. Phys Med. 2017;42:285–91. https://doi.org/10.1016/j.ejmp.2017.01.014.
Ott OJ, Niewald M, Weitmann HD, Jacob I, Adamietz IA, Schaefer U, Keilholz L, Heyd R, Muecke R, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: painful degenerative skeletal disorders. Strahlenther Onkol. 2015;191(1):1–6. https://doi.org/10.1007/s00066-014-0757-3.
Mücke R, Seegenschmiedt MH, Heyd R, Schafer U, Prott FJ, Glatzel M, Micke O. Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study. Strahlenther Onkol. 2010;186:7–17. https://doi.org/10.1007/s00066-009-1995-7.
Ott OJ, Hertel S, Gaipl US, Frey B, Schmidt M, Fietkau R. The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlenther Onkol. 2014;190(3):293–7. https://doi.org/10.1007/s00066-013-0504-1.
Ott OJ, Hertel S, Gaipl US, Frey B, Schmidt M, Fietkau R. The erlangen dose optimization trial for radiotherapy of benign painful shoulder syndrome. Long-term results. Strahlenther Onkol. 2014;190(4):394–8. https://doi.org/10.1007/s00066-013-0520-1.
Ott OJ, Jeremias C, Gaipl US, Frey B, Schmidt M, Fietkau R. Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial. Strahlenther Onkol. 2013;189:329–34. https://doi.org/10.1007/s00066-012-0256-3.
Donaubauer A-J, Zhou J-G, Ott OJ, Putz F, Fietkau R, Keilholz L, Gaipl US, Frey B, Weissmann T. Low dose radiation therapy, particularly with 0.5 Gy, improves pain in degenerative joint disease of the fingers: results of a retrospective analysis. Int J Mol Sci. 2020;21:5854. https://doi.org/10.3390/ijms21165854.
Kaltenborn A, Bulling E, Nitsche M, Carl UM, Hermann RM. The field size matters: low dose external beam radiotherapy for thumb carpometacarpal osteoarthritis: importance of field size. Strahlenther Onkol. 2016;192(8):582–8. https://doi.org/10.1007/s00066-016-0995-7 (English).
Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M, Kortekaas MC, Leer JW, Poortmans PMP, van den Hoogen FHJ, den Broeder AA, van den Ende CHM. Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial. Osteoarthr Cartil. 2018;26(10):1283–90.
Rogers S, Eberle B, Vogt DR, Meier E, Moser L, Gomez Ordoñez S, Desborough S, Riesterer O, Takacs I, Hasler P, Bodis S. Prospective evaluation of changes in pain levels, quality of life and functionality after low dose radiotherapy for epicondylitis, plantar fasciitis, and finger osteoarthritis. Front Med. 2020;7:195. https://doi.org/10.3389/fmed.2020.00195.
Ott OJ, Micke O, Mücke R, Niewald M, Rödel F, Schäfer U, Seegenschmiedt MH, Arenas M, Frey B, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). Low-dose radiotherapy: Mayday, mayday We’ve been hit! Strahlenther Onkol. 2019;195(4):285–8. https://doi.org/10.1007/s00066-018-1412-1.
Rüttermann M, Kaltenborn A, Trillmann A, Gutcke A, Hermann RM. Prospective evaluation of surgery vs. low dose external beam radiotherapy for painful thumb carpometacarpal osteoarthritis—a study protocol. Open J Orthop Rheumatol. 2016;1(1):015–7.
Acknowledgements
To Alyson Kim Turner, for reviewing, revising and editing this manuscript for English Language grammar and syntax.
Funding
The authors declare no financial disclosures.
Author information
Authors and Affiliations
Contributions
BA, AM study design, data analysis, manuscript writing. All the authors contributed to manuscript writing, editing and reviewing, reviewed previous drafts and provided comments and contributed to the final draft.
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare no conflict of interest regarding any aspect of the manuscript.
Ethical approval
All procedures performed were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration.
Informed consent
Informed consent was obtained from all individuals participants included in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Álvarez, B., Montero, A., Alonso, R. et al. Low-dose radiation therapy for hand osteoarthritis: shaking hands again?. Clin Transl Oncol 24, 532–539 (2022). https://doi.org/10.1007/s12094-021-02710-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-021-02710-w